|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Addiction specialist's role in liver transplantation procedures for alcoholic liver disease显示文摘Although liver transplantation(LT) is performed increasingly for patients with end-stage alcoholic liver disease(ALD), the topic remains controversial. Traditionally, the role of an addiction specialist focused on the screening and identification of patients with a high risk on relapse in heavy alcohol use. These patients were in many cases subsequently excluded from a further LT procedure.Recently, awareness is growing that not only screening of patients but also offering treatment, helping patients regain and maintain abstinence is essential, opening up a broader role for the addiction specialist(team)within the whole of the transplant procedure. Within this context, high-risk assessment is proposed to be an indication of increasing addiction treatment intensity,instead of being an exclusion criterion. In this review we present an overview regarding the state of the art on alcohol relapse assessment and treatment in patients with alcohol use disorders, both with and without ALD.Screening, treatment and monitoring is suggested as central roles for the addiction specialist(team) integrated within transplant centers. | Geert Dom Hendrik Peuskens | 2015 | World Journal of Hepatology2015，7，17： | 2 |
| 2 | Amisulpride improves de-pressive symptoms in acute exacerbations of schizophrenia:comparison with haloperidol and risperidone显示文摘 | Peuskens J M(O)ller HJ Puech A | | 0，，04： | 1 |
| 3 | A comparison of quetiapine and chlorpromazine in treatment of schizophrenia显示文摘 | Peuskens J Link CGG | 1997 | Acta Psychiatr Scand1997，94，4： | 1 |
| 4 | Risperidone in the treatment of patients with chronic schizophrenia:a multi-national,mult-center,double-blind,parallel-group study versus haloperidol(Risperidone Study Group)显示文摘 | Peuskens J | 1995 | Br J Psychiatry1995，166，： | 1 |
| 5 | Associative stigma in family members of psychotic patients in Flanders:An exploratory study显示文摘AIM: To assess presence and severity of associative stigma in family members of psychotic patients and factors for higher associative stigma.METHODS: Standardized semi-structured interview of 150 family members of psychotic patients receiving full time treatment. This study on associative stigma in family members of psychotic patients was part of a larger research program on the burden of the family, using 'Interview for the Burden of the Family' and the chapters stigma, treatment and attribution from the 'Family interview Schedule'. The respondents were relatives, one per patient, either partner or parent. The patients had been diagnosed with schizophrenia or schizo-affective disorder. All contacts with patients and relatives were in Dutch. Relatives were deemed suitable to participate in this research if they saw the patient at least once a week. Recruitment took place in a standardized way: after obtaining the patient's consent, the relatives were approached to participate. The results were analyzed using SPSS Version 18.0. RESULTS: The prevalence of associative stigma in this sample is 86%. Feelings of depression in the majority of family members are prominent. Twenty-one point three percent experienced guilt more or less frequent, while shame was less pronounced. Also, 18.6% of allrespondents indicated that they tried to hide the illness of their family member for others regularly or more. Three six point seven percent really kept secret about it in certain circumstances and 29.3% made efforts to explain what the situation or psychiatric condition of their family member really is like. Factors with marked significance towards higher associative stigma are a worsened relationship between the patient and the family member, conduct problems to family members, the patients' residence in a residential care setting, and hereditary attributional factors like genetic hereditability and character. The level of associative stigma has significantly been predicted by the burden of aggressive disruptions to family housemates of the psychotic patient.CONCLUSION: Family members of psychotic patients in Flanders experience higher associative stigma compared to previous international research. Disruptive behavior by the patient towards in-housing family members is the most accurate predictor of higher associative stigma. | Kirsten Catthoor Didier Schrijvers Joost Hutsebaut Dineke Feenstra Philippe Persoons Marc De Hert Jozef Peuskens Bernard Sabbe | 2015 | World Journal of Psychiatry2015，5，1： | 1 |
| 6 | A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia显示文摘 | Peuskens J Link CGG | 1997 | Acta Psychiatr Scand1997，96，： | 1 |
| 7 | Effectiveness of antipsy- choties in first-episode schizophrenia and schizophreniform disorder on response and remission: An open randomized clinical trial (EUFEST) 显示文摘 | Borer H Peuskens J Libiger J | 2009 | Sehizophr Res2009，115，23： | 1 |
| 8 | A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia显示文摘 | Peuskens J Link CGG | 1997 | Acta Psychiatr Scand1997，94，4： | 1 |
| 9 | Specificity of Regions Processing Biological Motion 显示文摘 | Peuskens H Vanrie J Verfaillie K | 2005 | Euro- pean Journal of Neuroseience2005，21，10： | 1 |
| 10 | Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder:results of an 8-week double-blind randomized controlled trial显示文摘 | Grootens KP van Veelen NM Peuskens J | 2011 | Schizophr Bull2011，37，2： | 1 |
| 11 | A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia 显示文摘 | Peuskens J Link CG | 1997 | Acta Psychiatr Scand1997，94，4： | 1 |
| 12 | A comparison of quetiapine and chlorprornazine in the treatment of schizophrenia显示文摘 | Peuskens J Link CGG | 1997 | Acta psychiatr Scand1997，94，4： | 1 |
| 13 | The effects of novel and newly approved antipsychotics on serum prolactin levels:a comprehensive review显示文摘 | Peuskens J Pani L Detraux J | 2014 | CNS Drugs2014，28，： | 1 |
| 14 | Effectiveness of antipsychotics in first- episode schizophrenia and schizophreniform disorder on re sponse and remission:An open randomized clinical triaI(EUFFST) 显示文摘 | Boter H Peusken J Libiger J | 2009 | Schizophr Res2009，115，23： | 1 |
| 15 | The effects of novel and newly approved antipsychotics on serum prolactin levels:a comprehensive review显示文摘 | Peuskens J Pani L Detraux J | 2014 | CNS Drugs2014，28，5： | 1 |
| 16 | Extracting 3D from motion: differences in human and monkey intraparietal cortex显示文摘 | Vanduffel W Fize D Peuskens H | 2002 | Science2002，298，5592： | 1 |
| 17 | Hepatotoxicity following treatmehnt with bromperidol显示文摘 | Van Bellinghen M Peuskens J Appelmans A | 1989 | J Clin Psychopharmacol1989，9，： | 1 |
| 18 | Extracting 3D from Motion:Differences in human and monkey intraparietal cortex显示文摘 | Vanduffel W Fize D Peuskens H | 2002 | Science2002，298，： | 1 |
| 19 | Amisulpride vs risperidone in chronic schizophrenia:results of a 6-month double-blind study显示文摘 | Sechter D Peuskens J Fleurot O | 2002 | Neuropsychopharmacology2002，27，6： | 1 |
| 20 | Second-generation and newly approved antipsychotics, serum prolactin levels and sex- ual dysfunctions: a critical literature review显示文摘 | De Herr M Detraux J Peuskens J | 2014 | Expert Opin Drug Saf2014，13，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员